Pregabalin Clonmel 300 mg capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

pregabalin clonmel 300 mg capsules, hard

clonmel healthcare ltd - pregabalin - capsule, hard - 300 milligram(s) - other antiepileptics; pregabalin

Nintedanib Clonmel 100mg soft capsules Malta - English - Medicines Authority

nintedanib clonmel 100mg soft capsules

clonmel healthcare limited waterford road, clonmel, co. tipperary e91 d768, ireland - soft capsule - nintedanib 100 mg - antineoplastic agents

Nintedanib Clonmel 150 mg soft capsules Malta - English - Medicines Authority

nintedanib clonmel 150 mg soft capsules

clonmel healthcare limited waterford road, clonmel, co. tipperary e91 d768, ireland - soft capsule - nintedanib 150 mg - antineoplastic agents

Cystadane European Union - English - EMA (European Medicines Agency)

cystadane

recordati rare diseases - betaine anhydrous - homocystinuria - other alimentary tract and metabolism products, - adjunctive treatment of homocystinuria, involving deficiencies or defects in:cystathionine beta-synthase (cbs);5,10-methylene-tetrahydrofolate reductase (mthfr);cobalamin cofactor metabolism (cbl).cystadane should be used as supplement to other therapies such as vitamin b6 (pyridoxine), vitamin b12 (cobalamin), folate and a specific diet.

Kinpeygo European Union - English - EMA (European Medicines Agency)

kinpeygo

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, intestinal antiinflammatory / antiinfective agents - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1.5 g/gram.

CYSTADANE betaine 1g/g oral powder bottle Australia - English - Department of Health (Therapeutic Goods Administration)

cystadane betaine 1g/g oral powder bottle

recordati rare diseases australia pty ltd - betaine, quantity: 1 g/g - powder, oral - excipient ingredients: - as an adjunct in the treatment of homocystinuria.

Olmesartan/Hydrochlorothiazide STADA Arzneimittel AG 20 mg/12.5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan/hydrochlorothiazide stada arzneimittel ag 20 mg/12.5 mg film-coated tablets

stada arzneimittel ag - olmesartan medoxomil; hydrochlorothiazide - film-coated tablet - 20 mg/12.5 milligram(s) - angiotensin ii antagonists and diuretics; olmesartan medoxomil and diuretics

Olmesartan/Hydrochlorothiazide STADA Arzneimittel AG 20 mg/25 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan/hydrochlorothiazide stada arzneimittel ag 20 mg/25 mg film-coated tablets

stada arzneimittel ag - olmesartan medoxomil; hydrochlorothiazide - film-coated tablet - 20 mg/25 milligram(s) - angiotensin ii antagonists and diuretics; olmesartan medoxomil and diuretics

Olmesartan/Hydrochlorothiazide STADA Arzneimittel AG 40 mg/12.5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan/hydrochlorothiazide stada arzneimittel ag 40 mg/12.5 mg film-coated tablets

stada arzneimittel ag - olmesartan medoxomil; hydrochlorothiazide - film-coated tablet - 40 mg/12.5 milligram(s) - angiotensin ii antagonists and diuretics; olmesartan medoxomil and diuretics

Olmesartan/Hydrochlorothiazide STADA Arzneimittel AG 40 mg/25 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan/hydrochlorothiazide stada arzneimittel ag 40 mg/25 mg film-coated tablets

stada arzneimittel ag - olmesartan medoxomil; hydrochlorothiazide - film-coated tablet - 40 mg/25 milligram(s) - angiotensin ii antagonists and diuretics; olmesartan medoxomil and diuretics